APA (7th ed.) Citation

Ugurel, S., Utikal, J., Helmbold, P., Leverkus, M., & Schadendorf, D. (2014). Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: A multicenter phase II DeCOG trial with long-term follow-up. Clinical cancer research, 20(2), . https://doi.org/10.1158/1078-0432.CCR-13-1411

Chicago Style (17th ed.) Citation

Ugurel, Selma, Jochen Utikal, Peter Helmbold, Martin Leverkus, and Dirk Schadendorf. "Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up." Clinical Cancer Research 20, no. 2 (2014). https://doi.org/10.1158/1078-0432.CCR-13-1411.

MLA (9th ed.) Citation

Ugurel, Selma, et al. "Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up." Clinical Cancer Research, vol. 20, no. 2, 2014, https://doi.org/10.1158/1078-0432.CCR-13-1411.